Clinical Trial Update: Cellular Immunotherapy for Patients With High Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial evaluating cellular immunotherapy for high-risk myelodysplastic syndromes and acute myeloid leukemia in Phase 1/Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes

Snippet

Sponsor: University of Campinas, Brazil | Conditions: Myelodysplastic Syndromes, Acute Myeloid Leukemia | Phase 1, Phase 2 | Status: UNKNOWN